Sitafloxacin Explained

Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic^[1] that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.

See also

• Quinolone

Further reading

• Keating GM . Sitafloxacin: in bacterial infections . Drugs . 71 . 6 . 731–44 . April 2011 . 21504249 . 10.2165/11207380-000000000-00000 . 195688876 .

External links

• Gracevit グレースビット (PDF) Daiichi Sankyo Co. January 2008.

Notes and References

1. Anderson DL . Sitafloxacin hydrate for bacterial infections . Drugs of Today . 44 . 7 . 489–501 . July 2008 . 18806900 . 10.1358/dot.2008.44.7.1219561 .